PMC6766113_01
Embryonic MRI that shows the abdominal cystic lesion.
CRIPE2019-6879168.001.jpg
PMC6766113_01_CRIPE2019-6879168.001.jpg
fig1
Echographic reevaluation at 29 weeks of gestation identified a slight enlargement of the mass (27 x 35 x 59 mm) that persisted during a second embryonic MRI 2 weeks later (see Figure 1).
Postnatal MRI depicts the enlargement of the lesion.
CRIPE2019-6879168.002.jpg
PMC6766113_01_CRIPE2019-6879168.002.jpg
fig2
AFP levels, and urine VMA levels. A new abdominal MRI was performed at day 9 of life and depicted an enlargement of the lesion (37 x 32 x 70 mm), while bone scan and 123I-MIBG scan were normal (see Figures 2(a) and 2(b)).
Intraoperative picture that shows the multicystic lesion attached to the spleen.
CRIPE2019-6879168.003.jpg
PMC6766113_01_CRIPE2019-6879168.003.jpg
fig3
Therefore, a complete mass excision with splenectomy was decided and performed (see Figures 3-5).
The spleen after the inevitable spleen-sparing operation.
CRIPE2019-6879168.004.jpg
PMC6766113_01_CRIPE2019-6879168.004.jpg
fig4
Therefore, a complete mass excision with splenectomy was decided and performed (see Figures 3-5).
The abdominal LMA.
CRIPE2019-6879168.005.jpg
PMC6766113_01_CRIPE2019-6879168.005.jpg
fig5
Therefore, a complete mass excision with splenectomy was decided and performed (see Figures 3-5).
PMC6766113_02